The value of HPV L1 and NuMA1 proteins in the prediction of cervical intraepithelial neoplasia associated with high-risk human papillomavirus
- Authors: Ershov V.A1, Lisyanskaya A.S1, Ronzhina E.A1, Rakhminova E.R1
-
Affiliations:
- City Clinical Oncology Dispensary
- Issue: No 11 (2017)
- Pages: 63-68
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248070
- DOI: https://doi.org/10.18565/aig.2017.11.63-68
- ID: 248070
Cite item
Abstract
Full Text
About the authors
V. A Ershov
City Clinical Oncology Dispensary
Email: ershov@gkod.spb.ru
PhD, chief of cytological laboratory St.-Petersburg
A. S Lisyanskaya
City Clinical Oncology Dispensary
Email: goronkod@zdrav.spb.ru
PhD, chief of gynecological department St.-Petersburg
E. A Ronzhina
City Clinical Oncology Dispensary
Email: goronkod@zdrav.spb.ru
oncologist of polyclinical department St.-Petersburg
E. R Rakhminova
City Clinical Oncology Dispensary
Email: goronkod@zdrav.spb.ru
oncologist of gynecological department St.-Petersburg
References
- Hernández-Hernández D.M., Apresa-García T., Patlán-Pérez R.M. Epidemiological overview of uterine cervical cancer. Rev. Med. Inst. Mex. Seguro. Soc. 2015; 53(Suppl. 2): S154-61.
- Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2015. 250с. [Kaprin A.D., Starinskij V.V., Petrova G.V., ed. Malignant neoplasms in Russia in 2013 (morbidity and mortality). Moscow: FGBU “MNIOI im. P.A. Gercena” Minzdrava Rossii; 2015. 250p. (in Russian)]
- Раннее выявление и комплексная диагностика рака шейки матки. Методические рекомендации. Л.: НИИО им. Н.Н. Петрова; 1977. 21с. [Early detection and comprehensive diagnosis of cervical cancer. Guidelines. Leningrad: NIIO im. N.N. Petrova; 1977. 21p. ( in Russian)]
- Шиллер-Волкова Н.Н., Никитина Н.И., Агамова К.А., Брин М.Л. Цитологическая диагностика злокачественных новообразований. Атлас. М.: Медицина; 1964. 263с. [Shiller-Volkova N.N., Nikitina N.I., Agamova K.A., Brin M.L. Cytological diagnosis of malignant neoplasms. Atlas. Moscow: Meditsina; 1964. 263p. (in Russian)]
- Costa C., Espinet B., Molina M.A., Salgado R., Salido M., Baró T. et al. Analysis of gene status in cervical dysplastic lesions and squamous cell carcinoma using tissue microarrays. Histol. Histopathol. 2009; 24(7): 821-9.
- Киселев В.И., Муйжнек Е.Л. Молекулярные механизмы развития дисплазии шейки матки: новые знания - новые возможности. М.; 2012. 19с. [Kiselev V.I., Mujzhnek E.L. Molecular mechanisms of development of cervical dysplasia: new knowledge - new opportunities. Moscow; 2012. 19p. (in Russian)]
- Griesser H., Sander H., Walczak C., Hilfrich R.A. HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions. Am. J. Clin. Pathol. 2009; 132(6): 840-5.
- Warren J.E., Silver R.M. Genetics of the cervix in relation to preterm birth. Semin. Perinatol. 2009; 33(5): 308-11.
- Stemberger-Papic S., Vrdoliyak-Mozetic D., Ostojic D.V., Rubesa-Mihaliyevic R., Manestar M. Evaluation of the HPV L1 capsid protein in prognosis of mild and moderate dysplasia of the cervix uteri. Coll. Antropol. 2010; 34(2): 419-23.
- Jung S.H., Choi Y.J., Kim M.S., Baek I.P., Lee S.H., Lee A.W. et al. Progression of naive intraepithelial neoplasia genome to aggressive squamous cell carcinoma genome of uterine cervix. Oncotarget. 2015; 6(6): 4385-93.
- D'Ottaviano M.G., Discacciati M.G., Andreoli M.A., Costa M.C., Termini L., Rabelo-Santos S.H. et al. HPV 16 is related to the progression of cervical intraepithelial neoplasia grade 2: a case series. Obstet. Gynecol. Int. 2013; 2013: 328909.
- Arias-Pulido H., Peyton C.L., Joste N.E., Vargas H., Wheeker C.M. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol. 2006; 44(5): 1755-62.
- Xue Y., Beilanger S., Zhang W., Lim D., Low J., Lunny D. et al. HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res. 2010; 70(13): 5316-25.
- Киселева В.И., Крикунова Л.И., Любина Л.В., Безяева Г.П., Панарина Л.В., Куевда Д.А. и др. Количественная нагрузка ВПЧ-16 и прогноз рака шейки матки. В кн.: Покровский В.И., ред. Сборник трудов VII Всероссийской научно-практической конференции с международным участием “Молекулярная диагностика-2010”. т. 3. М.; 2010: 368-70. [Kiseleva V.I., Krikunova L.I., Ljubina L.V., Bezjaeva G.P., Panarina L.V., Kuevda D.A. et al. The quantitative load of HPV-16 and the prognosis of cervical cancer. In the book.: Pokrovsky VI, ed. Collection of Proceedings of the VII All-Russian Scientific and Practical Conference with International Participation “Molecular Diagnostics-2010”. vol. 3. Moscow; 2010: 368-70. (in Russian)]
- Bergeron C., Ikenberg H., Sideri M., Denton K., Bogers J., Schmidt D. et al. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Cancer Cytopathol. 2015; 123(6): 373-81.
- Zhou W.Q., Sheng Q.Y., Sheng Y.H., Hou W.J., Xu G.X., Wu Y.M. et al. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application. Eur. J. Gynaecol. Oncol. 2015; 36(1): 62-8.
- Shukla S., Dass J., Pujani M. p53 and bcl2 expression in malignant and premalignant lesions of uterine cervix and their correlation with human papilloma virus 16 and 18. South Asian J. Cancer. 2014; 3(1): 48-53.
- Krishnappa P., Mohamad I.B., Lin Y.J., Barua A. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia. Diagn. Pathol. 2014; 9: 202.
- Chang M.S., Oh S., Jung E.J., Park J.H., Jeon H.W., Lee T.S. et al. High-risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer. APMIS. 2014; 122(5): 427-36.
- Vasilescu E., Ceauçu M., Tănase C., Stănculescu R., Vlădescu T., Ceauşu Z. P53, p63 and Ki-67 assessment in HPV-induced cervical neoplasia. Rom. J. Morphol. Embryol. 2009; 50(3): 357-61.
- Mulvany N.J., Allen D.G., Wilson S.M. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology. 2008; 40(4): 335-44.
- Xiao W., Bian M., Ma L., Liu J., Chen Y., Yang B. et al. Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions. Acta Cytol. 2010; 54(5): 661-7.
- Schmidt D. Precancerous lesions of the cervix. Biomarkers in cytological diagnosis. Pathologe. 2011; 32(6): 484-90.
- Ungureanu C., Socolov D., Anton G., Mihailovici M.S., Teleman S. Immunocytochemical expression of p16INK4a and HPV L1 capsid proteins as predictive markers of the cervical lesions progression risk. Rom. J. Morphol. Embryol. 2010; 51(3): 497-503.
- Korzeniewski N., Spardy N., Duensing A., Duensing S. Genomic instability and cancer: lessons learned from human papillomavirus. Cancer Lett. 2011; 305(2): 113-22.
- Nguyen C.L., Münger K. Human papillomavirus E7 protein deregulates mitosis via an association with nuclear mitotic apparatus protein 1. J. Virol. 2009; 83(4): 1700-7.
- Kivinen K., Taimen P., Kallajoki M. Silencing of Nuclear Mitotic Apparatus protein (NuMA) accelerates the apoptotic disintegration of the nucleus. Apoptosis. 2010; 15(8): 936-45.
- Apgar B.S., Zoschnick L., Wright T.C. Jr. The 2001 Bethesda system terminology. Am. Fam. Physician. 2003; 68(10): 1992-8.
- Kurman R.J., Carcangiu M.L., Herrington C.S., Young R. H., eds. WHO Classification of tumours of female reproductive organs. Lyon: IARC; 2014: 169-206.
- Kaplan K.J., Dainty L.A., Dolinsky B., Rose G.S., Carlson J., McHale M. et al. Prognosis and recurrence risk for patients with cervical squamous intraepithelial diagnosed during pregnancy. Cancer Cytopathol. 2004; 102(4): 228-32